Publications by authors named "Nasreen AlSayed"

Claim this Profile
N
Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook.
Vikrama Raja, Carlos Aguiar, Nasreen Alsayed, Yogeyaa S Chibber, Hussein ElBadawi

Atherosclerosis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East: 2021 update.
Nasreen Alsayed, Wael Almahmeed, Fahad Alnouri, Khalid Al-Waili, Hani Sabbour

Atherosclerosis· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry.
Khalid F Alhabib, Khalid Al-Rasadi, Turky H Almigbal, Mohammed A Batais, Ibrahim Al-Zakwani, Nasreen AlSayed

PLoS One· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Gulf Familial Hypercholesterolemia Registry (Gulf FH): Design, Rationale and Preliminary Results.
Khalid Al-Rasadi, Khalid F Alhabib, Faisal Al-Allaf, Khalid Al-Waili, Ibrahim Al-Zakwani, Nasreen AlSayed

Curr Vasc Pharmacol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and management of vitamin D deficiency in the Gulf Cooperative Council (GCC) countries: an expert consensus summary statement from the GCC vitamin D advisory board.
Yousef Al Saleh, Salem A Beshyah, Wiam Hussein, Abdulrazzaq Almadani, Ahmed Hassoun

Arch Osteoporos· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel.
Abdullah Al-Ashwal, Fahad Alnouri, Hani Sabbour, Abdulraof Al-Mahfouz, Nasreen Al-Sayed

Curr Vasc Pharmacol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral blood microRNA-15a is a potential biomarker for type 2 diabetes mellitus and pre-diabetes.
Ghada Al-Kafaji, Ghazi Al-Mahroos, Nasreen A Alsayed, Zuheir A Hasan, Sadia Nawaz

Mol Med Rep· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiotensin-converting enzyme inhibitors reduce albuminuria more than angiotensin receptor blockers in patients with type 2 diabetes.
Nasreen A Al-Sayed, Tianming Gao, Brian J Wells, Changhong Yu, Robert S Zimmerman

Endocr Pract· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of selective HLA class II susceptibility-conferring and protective haplotypes with type 2 diabetes in patients from Bahrain and Lebanon.
Wassim Y Almawi, Saria F Wakim-Ghorayeb, Mona R Arekat, Pierre Najm, Sose H Keleshian

Clin Vaccine Immunol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis